• Trius Therapeutics Inc., of San Diego, said underwriters of its previously announced public offering exercised in full their option to purchase an additional 1.29 million shares to cover overallotments. Including the overallotment, the company grossed $51.9 million from the sale of 9.89 million shares priced at $5.25 apiece.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST